Form4insider filings, from the source

SEC Form 5 · accession 0001209191-19-010097

HERON THERAPEUTICS, INC. /DE/ · HRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kevin C Tang
Director
Period of report
Dec 31, 2018
Accepted (ET)
Feb 14, 2019 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Dec 7, 2018G18,989$0.00D5,811,226IBy LP
Common StockF2Dec 7, 2018G18,989$0.00D5,792,237IBy LP
Common StockF2Dec 7, 2018G1,992$0.00D5,790,245IBy LP
Common StockF2Dec 10, 2018G19,304$0.00D5,770,941IBy LP
Common StockF2Dec 10, 2018G3,955$0.00D5,766,986IBy LP
Common StockF2Dec 10, 2018G3,955$0.00D5,763,031IBy LP
Common StockF2Dec 10, 2018G3,955$0.00D5,759,076IBy LP
Common StockF2Dec 10, 2018G2,025$0.00D5,757,051IBy LP
Common StockF2Dec 10, 2018G3,955$0.00D5,753,096IBy LP
Common StockF3holding———14,347IAs Trustee
Common StockF4holding———6,941D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses